Systematic reviews of alemtuzumab in renal transplantation by O'Callaghan, J, Morgan, R, Knight, SR, Morris, P

Systematic reviews of alemtuzumab in renal transplantation. by O'Callaghan, J, Morgan, R, Knight, SR, Morris, P

Steroid avoidance or withdrawal in renal transplantation. by Knight, SR, Morris, P

Skin cancers in renal transplant recipients by Bordea, C

“…It also confirmed the increased skin dryness in renal transplant patients, possibly a side effect of their medication. …”

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis by Currie, A, Knight, S, Morris, P

Triple therapy immunosuppression in cadaveric renal transplantation. by Richardson, A, Higgins, R, Ratcliffe, P, Ting, A, Murie, J, Morris, P

“…One hundred and ninety-two patients received 200 consecutive cadaver renal transplants (158 first and 42 regrafts) and were treated with triple therapy immunosuppression consisting of low-dose cyclosporin, azathioprine and prednisolone. …”

Total parathyroidectomy alone or with autograft for renal hyperparathyroidism? by Higgins, R, Richardson, A, Ratcliffe, P, Woods, C, Oliver, DO, Morris, P

“…In contrast, recurrent hyperparathyroidism was rare in renal transplant recipients with good renal function. …”

Lymphoproliferative disorders in Oxford renal transplant recipients. by Bates, W, Gray, D, Dada, M, Chetty, R, Gatter, K, Davies, DR, Morris, P

“…RESULTS: There were 1383 renal transplants in the study period and 27 patients developed lymphoma: 26 NHLs and one Hodgkin's disease (1.95%). …”

The quality of function of renal allografts is associated with donor age. by Higgins, R, Sheriff, R, Bittar, A, Richardson, A, Ratcliffe, P, Gray, D, Morris, P

“…The quality of renal allograft function was assessed by prospective measurement of creatinine clearance at 1 year (n = 197) and at 3 years (n = 115) after cadaveric renal transplantation in a cohort of 268 patients treated with triple therapy immunosuppression. …”

Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. by Marshall, SE, Bordea, C, Haldar, N, Mullighan, C, Wojnarowska, F, Morris, P, Welsh, K

“…The glutathione S-transferase enzymes play a major role in limiting the toxic effects of reactive oxygen species, and this study was designed to determine whether polymorphisms in these enzymes are associated with skin cancers in renal transplant recipients. METHODS: Two hundred twenty-two long-term survivors of renal transplantation were examined for polymorphisms in the GSTM1, GSTT1, and GSTP1 genes, using a unified polymerase chain reaction with sequence specific primers (PCR-SSP) genotyping method. …”

Specific and non-specific suppression of renal allograft rejection in the rat by Winearls, C, Winearls, Christopher Good

“…<p xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions">In this thesis certain clinically relevant aspects of specific and non-specific suppression of renal allograft rejection were examined in a rat renal allograft model.…”

The urological complications of renal transplantation: a series of 1535 patients. by Streeter, E, Little, D, Cranston, D, Morris, P

“…OBJECTIVE: To determine the incidence of urological complications of renal transplantation at one institution, and relate this to donor and recipient factors. …”

Hyperparathyroidism, hypertension and loop diuretic medication in renal transplant recipients. by Bittar, A, Ratcliffe, P, Richardson, A, Brown, R, Woodhead, J, Morris, P

“…It is postulated that loop diuretics exacerbate the hyperparathyroidism which complicates renal disease.…”

C4d deposition in early renal allograft protocol biopsies. by Koo, D, Roberts, I, Quiroga, I, Procter, J, Barnardo, M, Sutton, M, Cerundolo, L, Davies, DR, Friend, P, Morris, P, Fuggle, S

“… BACKGROUND: Deposition of the complement protein C4d in renal allograft biopsies obtained during graft dysfunction and rejection has been proposed to be a sensitive marker of antibody-mediated acute rejection. …”

Effect of intravenous infusion of atriopeptin 3 on immediate renal allograft function. by Ratcliffe, P, Richardson, A, Kirby, J, Moyses, C, Shelton, JR, Morris, P

“…Thus, despite the documentation of a protective effect of atrial natriuretic factor in animal models of renal ischemia, it is unlikely that intravenous infusion of AP-3 in this dose range will be of benefit in improving immediate renal allograft graft function.…”

C4d deposition in early renal allograft protocol biopsies by Roberts, I, Koo, D, Quiroga, I, Procter, J, Barnardo, M, Cerundolo, L, Davies, DR, Friend, P, Morris, P, Fuggle, S

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy. by Bittar, A, Ratcliffe, P, Richardson, A, Raine, A, Jones, L, Yudkin, P, Carter, R, Mann, J, Morris, P

“…To determine the extent of persisting hyperlipidemia in renal transplant recipients receiving modern maintenance immunosuppressive and antihypertensive therapy we compared plasma levels of total and high-density lipoprotein and triglyceride in 275 renal transplant recipients with stable graft function with age- and sex-matched groups from the local general population (n = 4055). …”

Subclinical rejection and borderline changes in early protocol biopsies following renal transplantation by Roberts, I, Reddy, S, Russell, C, Davies, DR, Friend, P, Handa, A, Morris, P

p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. by Marshall, SE, Bordea, C, Wojnarowska, F, Morris, P, Welsh, K

“…CONCLUSIONS: The p53 codon 72Arginine allele does not confer susceptibility to the development of skin tumors after renal transplantation.…”

Immunohistochemistry for C4d in renal allograft biopsies: Which method should be used? by Roberts, I, McWilliam, L, McEwen, A, Koo, D, Quiroga, I, Procter, J, Barnardo, M, Sutton, M, Cerundolo, L, Davies, DR, Friend, P, Morris, P, Fuggle, S